Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JACK DAVID SCHIM

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1346276375
CMS profile
151945
Location
CARLSBAD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$371,275.14

387 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Allergan, Inc. $81,768.32 76
AbbVie Inc. $71,964.11 114
Biohaven Pharmaceuticals, Inc. $69,050.22 76
Lilly USA, LLC $50,205.44 40
Teva Pharmaceuticals USA, Inc. $47,683.52 27
Amgen Inc. $23,431.97 18
Lundbeck LLC $12,658.04 15
UPSHER-SMITH LABORATORIES LLC $9,001.99 17
Eli Lilly and Company $3,000.00 1
Currax Pharmaceuticals LLC $1,500.00 1
Novartis Pharma AG $994.00 1
Almatica Pharma LLC $17.53 1

Page 2 of 8; records 51–100 of 387 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JACK DAVID SCHIM

NPI 1346276375 · CMS profile ID 151945

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

CARLSBAD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 8; records 51–100 of 387 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1346276375?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JACK DAVID SCHIM, NPI 1346276375, CMS profile ID 151945. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 8; records 51–100 of 387 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1346276375?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). JACK DAVID SCHIM, NPI 1346276375, CMS profile ID 151945. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 8; records 51–100 of 387 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1346276375?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
JACK DAVID SCHIM, NPI 1346276375, CMS profile ID 151945, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 8; records 51–100 of 387 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1346276375?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

387 matching records · $371,275.14 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 387 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 387.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $9.2810/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818553533 CMS
AbbVie Inc. $4,200.0010/13/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984463 CMS
AbbVie Inc. $182.5010/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984469 CMS
AbbVie Inc. $118.3410/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984473 CMS
AbbVie Inc. $344.0810/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984477 CMS
AbbVie Inc. $155.9510/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984483 CMS
AbbVie Inc. $448.4610/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984487 CMS
AbbVie Inc. $3,600.0010/13/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984491 CMS
AbbVie Inc. $214.2910/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984497 CMS
AbbVie Inc. $15.3410/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984501 CMS
Allergan, Inc. $750.0010/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792934461 CMS
AbbVie Inc. $26.4110/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984459 CMS
AbbVie Inc. $1,750.0010/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984453 CMS
Allergan, Inc. $750.0010/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792934459 CMS
Teva Pharmaceuticals USA, Inc. $113.9310/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839547031 CMS
Teva Pharmaceuticals USA, Inc. $441.4710/08/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839547033 CMS
Teva Pharmaceuticals USA, Inc. $3,960.0010/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839547037 CMS
Currax Pharmaceuticals LLC $1,500.0010/06/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792537103 CMS
Teva Pharmaceuticals USA, Inc. $3.8510/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839547081 CMS
AbbVie Inc. $27.6010/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984439 CMS
AbbVie Inc. $26.4010/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984445 CMS
AbbVie Inc. $12.2710/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795984449 CMS
Lundbeck LLC $1,125.0010/04/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845933331 CMS
Teva Pharmaceuticals USA, Inc. $7,920.0010/02/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839547027 CMS
Biohaven Pharmaceuticals, Inc. $3,000.0010/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616675 CMS
Biohaven Pharmaceuticals, Inc. $13.6810/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616677 CMS
Biohaven Pharmaceuticals, Inc. $262.6610/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616679 CMS
Biohaven Pharmaceuticals, Inc. $45.0410/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616681 CMS
Biohaven Pharmaceuticals, Inc. $23.7110/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616683 CMS
Biohaven Pharmaceuticals, Inc. $29.3810/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616685 CMS
Biohaven Pharmaceuticals, Inc. $4,000.0009/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616657 CMS
Biohaven Pharmaceuticals, Inc. $666.5009/30/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616659 CMS
Biohaven Pharmaceuticals, Inc. $45.0409/30/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616661 CMS
Biohaven Pharmaceuticals, Inc. $96.8409/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616663 CMS
Biohaven Pharmaceuticals, Inc. $2,000.0009/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616665 CMS
Biohaven Pharmaceuticals, Inc. $602.2209/30/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616667 CMS
Biohaven Pharmaceuticals, Inc. $23.7209/30/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616669 CMS
Biohaven Pharmaceuticals, Inc. $29.3909/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616671 CMS
Biohaven Pharmaceuticals, Inc. $15.3809/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616673 CMS
Biohaven Pharmaceuticals, Inc. $26.7509/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616635 CMS
Biohaven Pharmaceuticals, Inc. $4,000.0009/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616637 CMS
Biohaven Pharmaceuticals, Inc. $666.4909/29/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616639 CMS
Biohaven Pharmaceuticals, Inc. $179.0209/29/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616641 CMS
Biohaven Pharmaceuticals, Inc. $99.5109/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616643 CMS
Biohaven Pharmaceuticals, Inc. $1,500.0009/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616645 CMS
Biohaven Pharmaceuticals, Inc. $666.4809/29/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616647 CMS
Biohaven Pharmaceuticals, Inc. $179.0209/29/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616649 CMS
Biohaven Pharmaceuticals, Inc. $2,000.0009/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616651 CMS
Biohaven Pharmaceuticals, Inc. $666.4809/29/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616653 CMS
Biohaven Pharmaceuticals, Inc. $179.0209/29/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852616655 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $442,701.94 709
PY2020 $288,477.61 338
PY2021 $371,275.14 387
PY2022 $290,425.28 318
PY2023 $125,133.50 175
PY2024 $59,972.77 79
PY2025 $125,883.19 118

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $130,510.00 8
PY2024 Principal investigator $32,673.33 9
PY2021 Principal investigator $4,217.46 2
PY2020 Principal investigator $60,712.21 10
PY2019 Principal investigator $28,536.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $2,800.00 05/30/2025 Non-covered Recipient Entity
PROFOUND RESEARCH LLC
A Phase 2, Randomised, Multicentre, Parallel-Group Treatment, Double-Blind Study to Investigate the Safety and Efficacy of Subcutaneous MEDI0618 in the Reduction of Migraine Headache Days Compared to Placebo in Adult Participants With Episodic Migraine No dispute reported 06/30/2026 1202487145
Principal investigator 1 H. Lundbeck A S $93,600.00 04/08/2025 Non-covered Recipient Entity
PROFOUND RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251769490
Principal investigator 1 H. Lundbeck A S $1,800.00 04/01/2025 Non-covered Recipient Entity
PROFOUND RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251769162
Principal investigator 1 H. Lundbeck A S $1,680.00 04/01/2025 Non-covered Recipient Entity
PROFOUND RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251769220
Principal investigator 1 H. Lundbeck A S $1,800.00 04/01/2025 Non-covered Recipient Entity
PROFOUND RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251769224
Principal investigator 1 H. Lundbeck A S $2,280.00 04/01/2025 Non-covered Recipient Entity
PROFOUND RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251769245
Principal investigator 1 AstraZeneca UK Limited $21,550.00 01/29/2025 Non-covered Recipient Entity
PROFOUND RESEARCH LLC
a phase 2,randomised,multicentre, parallel group treatment,double blind study to investigate the safety and efficacy of subcutaneous MEDI0618 in the reduction of migraine headache days compared to placebo in adult participants with episodic migraine No dispute reported 06/30/2026 1185555607
Principal investigator 1 H. Lundbeck A S $5,000.00 01/23/2025 Non-covered Recipient Entity
PROFOUND RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251766676